In a bid to raise vital funds for the Steve Prescott Foundation charity and the other charities it supports, a team of eight cyclists have conquered a gruelling 3000-mile endurance race across some of the toughest terrain Europe has to offer.

Taking part in the Race Across Europe (RAC), the team consisting of Neil Prescott, Steve Hall, Darren Harrison, Ewan Dowes, Kevin Humphries, Phil Ellison, Gareth Ellis and Steve Hampson, all part of Boulting Ltd, managed to cover 3000 miles in just six days and raised more than £30,000 for charity. Split into two teams of four, riders were rotated meaning the team could cycle 24 hours a day to complete the challenge.

“Neil and the team should be incredibly proud of what they have accomplished,” said Josh Groarke, deputy group managing director at Boulting Ltd. “It is through their determination and that of similar groups, that vital funds are raised to support research for curing this diabolical disease.”

The riders part of the once in a lifetime event reached heights of 3000m above sea level and battled all manner of weather conditions, including wind, rain and hail, as well as temperatures of up to 40°C. The track started in Boulogne sur Mer, then up north through the French Ardennes and crossed the Rhine into Germany.

From there they climbed briefly into the Black Forest and then moved east across Germany and Austria, before heading south into Italy and Slovenia and over the Vršič Pass. The route then descended back into Italy, heading due west, crossing the Colle dell’Agnello back into France. They crossed the Alps twice and the Pyrenees once. The final gruelling push saw the group climb over Mont Ventoux and head south into Spain, where they reached their final destination.

The extreme endurance challenge was completed in aid of the Steve Prescott Foundation. Established in 2007 by Steve Prescott MBE, who was diagnosed with Pseudomyxoma Peritonei, a form of terminal cancer, and passed away in 2013, the foundation raises much needed funds for The Christie, Try Assist Fund and Oxford Transplant Centre.